Tsinghua University opened procurement for one automated protein-purification system supporting affinity and ion-exchange chromatography for proteins, complexes and viral vectors, including pilot-scale protein-drug and vaccine research.
The specification signals direct platform demand and potential recurring column and resin use. The notice is restricted to qualifying small and medium-sized manufacturers, so route-to-market eligibility needs early review.
Suggested next step
Assess qualification and local-bid requirements, then map the system, columns, resins and workflow support against the published specification.
Procurement deadline: 15 October 2026 at 09:30 Beijing time.
Madrid laboratory tenders for Agilent and Waters chromatography consumables
Spanish Ministry of Agriculture, Fisheries and Food
The Ministry opened a two-lot tender for chromatography consumables used with Agilent and Waters equipment at Madrid’s Agro-Food Arbitration Laboratory. The official notice values the requirement at €291,150.64.
This is a direct, current consumables-supply opportunity. Product equivalence, approved specifications and quality-certificate requirements need to be checked before deciding whether to bid.
Suggested next step
Obtain the specifications and lot lists now, map eligible products and local route to market, and decide whether to bid directly or through a qualified Spanish partner.
Procurement deadline: 9 October 2026 at 12:00 Madrid time.
National LC-MS framework opens for Spanish clinical laboratories
Instituto Nacional de Gestión Sanitaria (INGESA)
Spain’s health procurement authority opened a 24-month national framework for standard LC-MS/MS, high-performance LC-MS/MS and HRMS systems for National Health System clinical laboratories. The official notice proposes up to ten operators and estimates the framework at €97.35 million.
Open procurement & national frameworkClinical laboratories & healthcareHPLC / UHPLCLC-MSClinical mass spectrometryGeneral instruments
Why it matters & suggested action
Why it may matter
This is a current supplier-qualification opportunity with potential follow-on requirements for columns, sample preparation, service and workflow support. Exact accessory and consumables scope must be checked in the tender documents.
Suggested next step
Review the three lots and participation requirements immediately, then determine direct-bid, manufacturer-partner or complementary-consumables routes before the deadline.
Procurement deadline: 9 October 2026 at 23:59 Madrid time.
Indian Institute of Science Education and Research Pune
IISER Pune issued tender IISER/PUR/0690/26 for an FPLC system for protein purification on 7 September. Its official tender page sets a 28 September closing date.
The system purchase may create a direct instrument opportunity and follow-on resin, column and applications-support demand. Technical scope and eligibility remain subject to the tender document.
Suggested next step
Review the tender specification immediately and assess an instrument bid or local partnership plus follow-on columns, resins and training support.
This is a current instrument opportunity with likely downstream requirements for columns, liners, septa, vials and applications support, subject to the detailed specification.
Suggested next step
Open the official procurement pack, confirm instrument and detector requirements, and assess a direct or Japanese-channel bid before submission closes.
Procurement deadline: 29 September 2026; bid opening is scheduled for 9 October.
Shimadzu launches combustion IC system for PFAS screening
Shimadzu Corporation
Shimadzu released a combustion ion chromatography system in Japan and overseas on 1 September. It combines an AQF-5000H combustion unit, IC-150 ion chromatograph and C-IC Solution software, with an EPA Method 1621 template for adsorbable organic fluorine screening.
The launch broadens Shimadzu’s PFAS and environmental-testing offer and may create competitive, complementary-consumables and channel conversations around ion chromatography, sample collection and confirmatory LC-MS workflows. No distributor requirement is stated.
Suggested next step
Assess regional launch coverage and identify laboratories or channel partners building EPA Method 1621 and PFAS screening workflows before approaching with complementary consumables or applications support.
Global product release announced; no procurement deadline or distributor search stated.
Southampton is recruiting a manager for its chromatography and mass-spectrometry facility, which supports internal, external and commercial users across LC-MS, SFC-MS and GC-MS. The vacancy cites recent investment, funding successes and expected activity growth.
The combination of funded growth, a new facility manager and 13,000 annual sample analyses makes this a credible account-development signal for columns, sample handling and specialist workflow support. No purchase is announced.
Suggested next step
Qualify current platforms, method-development priorities and supplier arrangements after the new manager is appointed; do not treat the vacancy as a tender.
Capability-growth signal; no procurement deadline stated.
Emerging / InvestigateLoughborough · East MidlandsIdentified 18 Sept 2026
Analytical capacity and further growth at Charnwood
Almac Pharma Services
Almac’s ten-year review of Charnwood describes expanded analytical laboratory capacity, analytical development and QC testing. It reports more than 350 employees and plans for further growth.
Capacity expansionPharmaceutical development & QCHPLC / UHPLCSample preparationGeneral consumables
Why it matters & suggested action
Why it may matter
Analytical development and QC may support demand for chromatography and sample-preparation consumables. The announcement reviews investments over several years; it does not date a new purchasing project or specify instruments.
Suggested next step
Establish which analytical workflows are expanding and whether any supplier qualification or method-development work is planned.
Account-development signal; no purchasing deadline announced.
King’s is recruiting a senior analyst for its Drug Control Centre’s LC-MS team, working with HRMS, tandem LC-MS and biological samples. The role includes routine anti-doping analysis and method development.
An identifiable LC-MS workflow makes this a relevant account to investigate for columns and sample-handling consumables. Recruitment alone does not establish growth, a new budget or a purchasing requirement.
Suggested next step
Check existing account coverage and ask the laboratory about current methods and consumable performance needs before proposing products.
Vacancy closes 4 October; this is not a procurement deadline.
UHPLC-MS upgrade and NIH-funded ZenoTOF expand analytical capacity
University of Wisconsin–Madison
UW–Madison's Analytical Instrumentation Center received support to upgrade an UHPLC/triple-quadrupole system and a $1.03 million NIH grant for a SCIEX ZenoTOF 8600 expected to serve 23 users across 66 federal contracts or grants.
Funded research capability expansionPharmaceutical & academic researchUHPLCLC-MS/MSHigh-resolution mass spectrometryZenoTOF
Why it matters & suggested action
Why it may matter
Two funded LC-MS capability additions create an identifiable installed-base opportunity for columns, sample preparation, vials, service and application support across multiple research programmes.
Suggested next step
Map the centre's incoming UHPLC-MS workflows and qualify method-development and recurring consumables requirements.
Official university article published 16 September 2026. It describes awarded funding and planned capability, not an open procurement.
Protein-production team expansion covers FPLC and purification workflows
Elanco
Elanco's official careers site advertised a Protein Production Team Lead role describing team expansion and workflows including ÄKTA/FPLC, affinity chromatography, ion exchange, SEC, HPLC and protein purification.
Explicit team expansion across multiple purification modes indicates potential growth in resin, column, buffer, filtration and workflow-support demand.
Suggested next step
Qualify whether the enlarged team is adding purification capacity and identify resin, column and sample-preparation requirements.
Official vacancy published 10 September 2026. The source remains on Elanco's careers host but its text was not crawlable during the 22 September recheck; this is a capability signal, not a procurement deadline.
AddLife announced its acquisition of Unicam Sistemas Analíticos on 9 September. Unicam distributes analytical instruments and consumables in Portugal across chromatography, spectrometry and microwave technology, with about €10 million annual revenue and 20 employees.
The change in ownership may affect supplier priorities, portfolio development and channel strategy in Portugal. It is a relevant signal for manufacturers assessing representation, competitive position or complementary product fit, but no immediate appointment opportunity is stated.
Suggested next step
Review Unicam’s current chromatography portfolio and ownership transition, then qualify whether the acquisition creates gaps, conflicts or complementary channel opportunities in Portugal.
Acquisition closed 8 September and was announced 9 September; no distributor appointment deadline stated.
New Orbitrap Astral expands LC-MS proteomics capacity
University of Nebraska–Lincoln
UNL installed a Thermo Scientific Orbitrap Astral in its Proteomics and Metabolomics Facility. The fee-for-service core says the system increases high-throughput LC-MS capacity and supports about 120 researchers each year.
Research capability growthAcademic, agricultural & biomedical researchLC-MSHigh-resolution mass spectrometryProteomicsMetabolomicsSample preparation
Why it matters & suggested action
Why it may matter
The expanded installed base can create recurring qualification opportunities around LC consumables, sample preparation, vials and workflow support for proteomics and metabolomics users.
Suggested next step
Qualify the core facility's LC and sample-preparation workflows and identify complementary consumables or method-support needs.
Official capability announcement published 4 September 2026; the instrument began operations in June 2026. No procurement deadline is stated.
Acquisition adds a major LC-MS/MS bioanalytical laboratory
Fortrea / Worldwide Clinical Trials
Fortrea announced the acquisition of Worldwide Clinical Trials' 60,000 sq ft GLP bioanalytical laboratory in Austin. Worldwide's official capability page documents 600 validated LC-MS/MS methods and broad small- and large-molecule bioanalysis.
Acquisition & laboratory capability expansionClinical development & pharmaceutical bioanalysisLC-MS/MSHigh-resolution mass spectrometryBioanalysisSample preparationLaboratory automation
Why it matters & suggested action
Why it may matter
Ownership transition around a large LC-MS/MS laboratory creates an account-qualification opportunity for platform standardisation, methods, columns, sample preparation and recurring consumables.
Suggested next step
Track integration decisions and qualify any supplier, platform or consumables standardisation arising from the ownership change.
Acquisition announced 2 September 2026. Fortrea's investor page returned an automated-access block on 22 September; Worldwide's current official capability page remained accessible.
Metrohm launched OMNIS IC on 1 September as a modular ion-chromatography platform with automation and inline sample-preparation options including filtration and dialysis.
A global platform launch can create channel, competitive and complementary-consumables opportunities around IC columns, suppressors, eluents, filtration and sample-handling workflows. Metrohm did not announce a distributor search.
Suggested next step
Qualify regional launch coverage and identify laboratories reviewing IC workflows where complementary consumables, sample preparation or applications support may be relevant.
Global product launch; no procurement deadline or distributor requirement stated.
Monitor / Longer-termDaresbury · North WestIdentified 18 Sept 2026
New biotechnology laboratories at Daresbury
Croda
Croda announced the opening of biotechnology R&D laboratories at Sci-Tech Daresbury on 17 September, supporting research into ingredients and technologies.
New laboratoryBiotechnology R&DGeneral consumables
Why it matters & suggested action
Why it may matter
A new laboratory is worth qualifying, but the announcement does not establish a specific chromatography workflow or consumables requirement. Treat this as a lower-confidence account signal.
Suggested next step
First establish whether analytical separation or purification is performed on site and whether supplier arrangements are already in place.
Opening announced; no purchasing requirement confirmed.
Monitor / Longer-termPalmerston North · New ZealandIdentified 17 Sept 2026
New Zealand bioeconomy institute replaces end-of-life Orbitrap
New Zealand Institute for Bioeconomy Science
New Zealand’s official procurement service records a sole-agency award to Thermo Fisher Scientific New Zealand to replace an end-of-life Q-Exactive Orbitrap LC-MS/MS system for the institute’s AG Science unit.
The award is not an open sales opportunity, but it identifies a new LC-MS installed base and a likely future need for columns, vials, sample preparation and applications support. Supplier arrangements may already be committed.
Suggested next step
Record the installed-base change and qualify future consumables and workflow needs without presenting this as an open tender.
Award dated 17 September 2026; this is account intelligence, not an open procurement.
SBS BEYONDQUEST™ is in beta. Complimentary access is currently available during the launch phase.
Features, availability and access may change. No payment details are required.
SBS BEYONDQUEST™ uses automated analysis of public information and may contain errors, omissions or outdated material. Factual summaries and SBS interpretations are shown separately. Signals do not confirm a purchasing requirement, available budget or intention to buy. Verify the original source and current status before acting. Global coverage is selective, not exhaustive; inclusion does not imply endorsement or a relationship with SBS.
Privacy-conscious audience measurement records page and BEYONDQUEST™ interactions without analytics cookies. Raw IP addresses and full user-agent strings are not stored. Privacy notice.
Solomon’s Business Systems is a trading style of Richard James Solomon, sole trader.
E&OEErrors and omissions excepted. Information on this website is provided in good faith for general information and may be amended or corrected without notice.
* Independence acknowledgementSolomon’s Business Systems is an independent consultancy and is not affiliated with, endorsed by or sponsored by Danaher Corporation. References to Danaher relate solely to Richard Solomon’s previous employment and professional experience.
